Company Filing History:
Years Active: 2024
Title: Jamie M Schiffer: Innovator in Pharmaceutical Science
Introduction
Jamie M Schiffer is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that modulate monoacylglycerol lipase (MGL). Her work has the potential to impact various medical conditions, including pain management and psychiatric disorders.
Latest Patents
Jamie M Schiffer holds a patent for "Monoacylglycerol lipase modulators - Fused and bridged compounds of Formula (I), and pharmaceutically acceptable salts, isotopes, N-oxides, solvates, and stereoisomers thereof, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with MGL modulation, such as those associated with pain, psychiatric disorders, neurological disorders (including, but not limited to major depressive disorder, treatment resistant depression, anxious depression, autism spectrum disorders, Asperger syndrome, bipolar disorder), cancers and eye conditions." This patent highlights her innovative approach to addressing complex health issues.
Career Highlights
Jamie is currently employed at Janssen Pharmaceutica NV, where she continues to advance her research and development efforts. Her work at this leading pharmaceutical company allows her to collaborate with other experts in the field and contribute to groundbreaking medical solutions.
Collaborations
Some of her notable coworkers include Michael K Ameriks and Brian Ngo Laforteza. Their collaboration fosters a dynamic environment for innovation and research.
Conclusion
Jamie M Schiffer is a trailblazer in the pharmaceutical industry, with a focus on developing novel treatments for various medical conditions. Her contributions through her patent and work at Janssen Pharmaceutica NV exemplify her commitment to improving healthcare outcomes.